<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>14</Volume>
				<Issue>10</Issue>
				<PubDate PubStatus="epublish">
					<Year>2013</Year>
					<Month>10</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Lack of Association of Three Common Polymorphisms in Toll-like receptors (TLRs), TLR2+597T>C, +1350C>T and Arg753Gln with Cancer Risk: a Meta-analysis</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>5871</FirstPage>
			<LastPage>5876</LastPage>
			<ELocationID EIdType="pii">28221</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>&lt;b&gt;Background:&lt;/b&gt; Single nucleotide polymorphisms (SNPs) occurring in Toll-like receptors (TLRs) may contributeto cancer risk. Many polymorphisms of TLR2 have been studied for associations, but the findings are conflicting.Methodology/Principal Findings: We performed a meta-analysis of 14 studies to confirm the association betweenTLR2+597T&gt;C (rs3804099), +1350C&gt;T (rs3804100) and Arg753Gln (rs5743708) polymorphisms and cancerrisk. Odds ratio (OR) and 95% confidence intervals (95% CI) were used to assess the strength of associations.There was no significant association between TLR2+597T&gt;C and cancer risk in the codominant models (CCvs. TT: OR = 1.01, 95%CI = 0.86-1.17, Pheterogeneity = 0.148; CT vs. TT: OR = 0.92, 95%CI = 0.69-1.23, Pheterogeneity&lt; 0.001), the recessive model (CC vs. CT+TT: OR = 0.86, 95%CI = 0.67-1.10, Pheterogeneity = 0.007) , the dominantmodel (CC+CT vs. TT: OR = 0.93, 95%CI = 0.76-1.15, Pheterogeneity = 0.001) and the allele model (C vs. T: OR =0.93, 95%CI = 0.81-1.08, Pheterogeneity = 0.019). Similarly, no significant associations between TLR2+1350C&gt;T,Arg753Gln polymorphisms and cancer risk were found. However, in the sub-group analysis of ethnicities, thetrend of pooled ORs in Asians was opposite to Caucasians. &lt;br/&gt;&lt;b&gt;Conclusions&lt;/b&gt;: The present meta-analysis suggeststhat TLR2+597T&gt;C (rs3804099), +1350C&gt;T (rs3804100) and Arg753Gln (rs5743708) polymorphisms are notassociated with cancer risk.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Toll-like receptor 2</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Polymorphism</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Meta-analysis</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_28221_2cff408c7636316544978cfd85ee4a14.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
